- In November 2022, Bio INX introduced Hydrobio INX 400, a ground-breaking material that enables live cell encapsulation in 3D printing using Nanoscribe's two-photon polymerization technology. This material is designed for cell encapsulation combined with cell seeding to create complex biomimetic tissues
- In March 2022, PharmaCyte Biotech, Inc. successfully completed a 24-month product stability study for its clinical trial product candidate, CypCaps, as required by the U.S. Food and Drug Administration (FDA). This milestone demonstrates that CypCaps can maintain a shelf life of at least 24 months when stored at -80°C
